Genetics of Crohn disease, an archetypal inflammatory barrier disease
暂无分享,去创建一个
Mario Albrecht | Michael Krawczak | Philip Rosenstiel | Jochen Hampe | Stefan Schreiber | J. Hampe | S. Schreiber | P. Rosenstiel | M. Krawczak | M. Albrecht | S. Schreiber
[1] J. Cavanaugh,et al. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. , 2001, American journal of human genetics.
[2] G. Churchill,et al. Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. , 1999, Genomics.
[3] Thomas Lengauer,et al. Structural localization of disease‐associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2 , 2003, FEBS letters.
[4] C. Elson,et al. Heritable Susceptibility for Colitis in Mice Induced by IL‐10 Deficiency , 2000, Inflammatory bowel diseases.
[5] Alastair Forbes,et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.
[6] Howard C. Berg,et al. Genetic analysis , 1957, Nature Biotechnology.
[7] T. Sørensen,et al. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. , 1993, BMJ.
[8] H. Aihara,et al. Mapping of a disease susceptibility locus in chromosome 6p in Japanese patients with ulcerative colitis , 2004, Genes and Immunity.
[9] Bill Newman,et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease , 2004, Nature Genetics.
[10] F. Martinon,et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.
[11] Richard Beasley,et al. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC , 1998, The Lancet.
[12] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.
[13] Luc J. Smink,et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease , 2003, Nature.
[14] D. Botstein,et al. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.
[15] S. Targan,et al. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. , 1999, Inflammatory bowel diseases.
[16] M. Parkes,et al. Contribution of the IL‐2 and IL‐10 genes to inflammatory bowel disease (IBD) susceptibility , 1998, Clinical and experimental immunology.
[17] Jean Weissenbach,et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16 , 1996, Nature.
[18] S. Fisher,et al. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. , 2003, American journal of human genetics.
[19] R Balfour Sartor,et al. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. , 2004, Gastroenterology.
[20] P. Rosenstiel,et al. TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells ☆ ☆☆ ★ ★★ ♢ , 2003 .
[21] S. Fanaro,et al. Intestinal microflora in early infancy: composition and development , 2003, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[22] D. Podolsky,et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. , 2003, Gastroenterology.
[23] Michael Karin,et al. Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing , 2005, Science.
[24] J. Ting,et al. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. , 2005, Annual review of immunology.
[25] W. Kruis. Review article: antibiotics and probiotics in inflammatory bowel disease. , 2004, Alimentary pharmacology & therapeutics.
[26] B. Xia,et al. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. , 2004, World journal of gastroenterology.
[27] E. Koonin,et al. STAND, a class of P-loop NTPases including animal and plant regulators of programmed cell death: multiple, complex domain architectures, unusual phyletic patterns, and evolution by horizontal gene transfer. , 2004, Journal of molecular biology.
[28] S. Yamaoka,et al. Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.
[29] C. Shin,et al. Cell signalling and the control of pre-mRNA splicing , 2004, Nature Reviews Molecular Cell Biology.
[30] E. Lindberg,et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn’s disease: an inherited defect in mucosal defence? , 1999, Gut.
[31] T. Hibi,et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. , 2002, Gastroenterology.
[32] M. Shriver,et al. Interrogating a high-density SNP map for signatures of natural selection. , 2002, Genome research.
[33] M. Hornef,et al. Toll-like Receptor 4 Resides in the Golgi Apparatus and Colocalizes with Internalized Lipopolysaccharide in Intestinal Epithelial Cells , 2002, The Journal of experimental medicine.
[34] L. Cardon,et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. , 2002 .
[35] K. Huse,et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2 , 2005, Nature Genetics.
[36] Judy H. Cho,et al. [Letters to Nature] , 1975, Nature.
[37] L. Cardon,et al. Fine mapping of the IBD1 locus did not identify Crohn disease-associated NOD2 variants: implications for complex disease genetics. , 2002, American journal of medical genetics.
[38] J. Hampe,et al. Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure , 2003, International Journal of Colorectal Disease.
[39] M. Daly,et al. Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Daly,et al. Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies , 2001, Gut.
[41] T. Sørensen,et al. Familial occurrence of inflammatory bowel disease. , 1991, The New England journal of medicine.
[42] R. Pounder,et al. Genetics versus environment in inflammatory bowel disease: results of a British twin study , 1996, BMJ.
[43] J. Bach,et al. The effect of infections on susceptibility to autoimmune and allergic diseases. , 2002, The New England journal of medicine.
[44] Richard A. Flavell,et al. Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.
[45] J. Valentine,et al. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease , 2004, The Lancet.
[46] E S Lander,et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. , 2000, American journal of human genetics.
[47] Thomas Lengauer,et al. Genetic variation in DLG5 is associated with inflammatory bowel disease , 2004, Nature Genetics.
[48] S. Dinesh-Kumar,et al. Alternatively spliced N resistance gene transcripts: their possible role in tobacco mosaic virus resistance. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Salminen,et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial , 2001, The Lancet.
[50] J. Pritchard,et al. The allelic architecture of human disease genes: common disease-common variant...or not? , 2002, Human molecular genetics.
[51] M. Daly,et al. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. , 2003, American journal of human genetics.
[52] N E Morton,et al. Tests and estimates of allelic association in complex inheritance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Pritchard,et al. Use of unlinked genetic markers to detect population stratification in association studies. , 1999, American journal of human genetics.
[54] M. Abreu,et al. Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide1 , 2001, The Journal of Immunology.
[55] V. Binder. Epidemiology of IBD during the twentieth century: an integrated view. , 2004, Best practice & research. Clinical gastroenterology.
[56] J. Ting,et al. Cutting Edge: CATERPILLER: A Large Family of Mammalian Genes Containing CARD, Pyrin, Nucleotide-Binding, and Leucine-Rich Repeat Domains1 , 2002, The Journal of Immunology.
[57] C. Jobin. Intestinal epithelial cells and innate immunity in the intestine: is CARD15/Nod2 another player? , 2003, Gastroenterology.
[58] H. Lochs,et al. Intestinal permeability and the prediction of relapse in Crohri's disease , 1993, The Lancet.
[59] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[60] J. Rotter,et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. , 1989, Gastroenterology.
[61] F. Majewski,et al. The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. , 1989, American journal of medical genetics.
[62] V. Sperandio,et al. Cell-to-cell signaling in intestinal pathogens. , 2004, Current issues in intestinal microbiology.
[63] J. Sundberg,et al. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[64] Yusuke Nakamura,et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease , 2004, Journal of Human Genetics.
[65] A. Macpherson,et al. Interactions between commensal intestinal bacteria and the immune system , 2004, Nature Reviews Immunology.
[66] B. Müller-Myhsok,et al. Results from a genome-wide search for predisposing genes in sarcoidosis. , 2001, American journal of respiratory and critical care medicine.
[67] A. Peña,et al. Environmental risk factors in inflammatory bowel disease. , 1996, Hepato-gastroenterology.
[68] F. Rocca,et al. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). , 1992, Gastroenterology.
[69] L. Cardon,et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. , 1999, American journal of human genetics.
[70] M. Loreau,et al. Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[71] J. Trent,et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[72] S. Fisher,et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.
[73] J. Sundberg,et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[74] Yi Xing,et al. Assessing the impact of alternative splicing on domain interactions in the human proteome. , 2004, Journal of proteome research.
[75] L. Newman,et al. Medical progress : Sarcoidosis , 1997 .
[76] Rolf Backofen,et al. Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity , 2004, Nature Genetics.
[77] Sinead B. O'Leary,et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.
[78] J. Weber,et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[79] G. Oppenheimer,et al. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer. , 1984, JAMA.
[80] W. Ewens,et al. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.
[81] D. Coggon,et al. Inflammatory bowel disease and domestic hygiene in infancy , 1994, The Lancet.
[82] T. Ahmad,et al. Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. , 2003, American journal of human genetics.
[83] J. Gordon,et al. Commensal Host-Bacterial Relationships in the Gut , 2001, Science.
[84] S. Dinesh-Kumar,et al. Structure-function analysis of the tobacco mosaic virus resistance gene N. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[85] N. Wood,et al. Genetic association studies , 2001, Neurology.
[86] K. Huse,et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations , 2003, European Journal of Human Genetics.
[87] W. Walker. Role of nutrients and bacterial colonization in the development of intestinal host defense. , 2000, Journal of pediatric gastroenterology and nutrition.
[88] K. Welsh,et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. , 2001, American journal of respiratory cell and molecular biology.
[89] M Schwab,et al. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.
[90] V. Godfrey,et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[91] E. Jabs,et al. American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. , 1998, Gastroenterology.
[92] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[93] W. Walker,et al. Protective nutrients and bacterial colonization in the immature human gut. , 1999, Advances in pediatrics.
[94] J. Mcghee,et al. Murine bone marrow IgA responses to orally administered sheep erythrocytes. , 1986, Journal of immunology.
[95] L. Tsui,et al. Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.
[96] D. Gudbjartsson,et al. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? , 2003, Gastroenterology.
[97] J. Hampe,et al. Patterns of linkage disequilibrium in the MHC region on human chromosome 6p , 2004, Human Genetics.
[98] E. Lindberg,et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. , 1988, Gut.
[99] D. D. Jong,et al. NOD 2 mediates anti-inflammatory signals induced byTLR 2 ligands : implications for Crohn ’ s disease , 2004 .
[100] J. Hampe,et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.
[101] N. Risch. Searching for genetic determinants in the new millennium , 2000, Nature.
[102] J. Ting,et al. Cutting Edge: CIAS1/Cryopyrin/PYPAF1/NALP3/ CATERPILLER 1.1 Is an Inducible Inflammatory Mediator with NF-κB Suppressive Properties , 2003, The Journal of Immunology.
[103] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[104] A. Gewirtz. Intestinal epithelial toll-like receptors: to protect. And serve? , 2003, Current pharmaceutical design.
[105] L. Tsui,et al. Identification of the cystic fibrosis gene: genetic analysis. , 1989, Science.
[106] J. Terwilliger,et al. Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 , 1996, Nature Genetics.
[107] S. Foster,et al. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.
[108] Daniel J Schaid,et al. Genetic epidemiology and haplotypes , 2004, Genetic epidemiology.
[109] J. Pritchard,et al. Evidence for extensive transmission distortion in the human genome. , 2004, American journal of human genetics.
[110] M. Daly,et al. New Approaches to Gene Hunting in IBD , 2004, Inflammatory bowel diseases.
[111] B. Franke,et al. NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease , 2004, European journal of immunology.
[112] K. Huse,et al. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[113] J. Marshall,et al. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. , 2000, Gastroenterology.
[114] N J Lynch,et al. Linkage of inflammatory bowel disease to human chromosome 6p. , 1999, American journal of human genetics.
[115] Thomas Lengauer,et al. Disease-associated variants in PYPAF1 and NOD2 result in similar alterations of conserved sequence , 2003, Bioinform..
[116] S. Cannon,et al. Structural, expression, and evolutionary analysis of mouse CIAS1. , 2004, Gene.
[117] W. Kruis,et al. Antibiotics and probiotics in inflammatory bowel disease , 2004, Alimentary pharmacology & therapeutics.
[118] L. Cardon,et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. , 1998, Gastroenterology.
[119] J. Satsangi,et al. The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease , 1994 .
[120] M. Kagnoff,et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. , 1999, Journal of immunology.
[121] D J Schaid,et al. Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. , 1999, American journal of epidemiology.
[122] S. Dinesh-Kumar,et al. Structure – function analysis of the tobacco mosaic virus resistance gene , 2000 .
[123] M. Daly,et al. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. , 2004, Human molecular genetics.
[124] Julian P T Higgins,et al. Obstacles and opportunities in meta-analysis of genetic association studies , 2005, Genetics in Medicine.
[125] C. V. van Duijn,et al. Genetic association studies: genes in search of diseases. , 2002, Neurology.
[126] M. Chamaillard,et al. Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.
[127] Masaru Mitsushima,et al. Interaction of lp-dlg/KIAA0583, a Membrane-associated Guanylate Kinase Family Protein, with Vinexin and β-Catenin at Sites of Cell-Cell Contact* , 2003, Journal of Biological Chemistry.
[128] M. Iannuzzi,et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. , 2003, American journal of human genetics.
[129] J. Nadeau,et al. Finding Genes That Underlie Complex Traits , 2002, Science.
[130] K. Ewe,et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) , 1995, Clinical and experimental immunology.
[131] S. Hampson. Randomised, placebo-controlled trial , 2002 .
[132] L. Cardon,et al. The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. , 2003, Human molecular genetics.
[133] Genes in search of diseases , 2001 .
[134] H. Deng,et al. Re: "Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions". , 2000, American journal of epidemiology.
[135] K. McCann. The diversity–stability debate , 2000, Nature.
[136] Ruth E. Hartley,et al. An integrated view. , 1973 .
[137] D. Podolsky,et al. Lipopolysaccharide Activates Distinct Signaling Pathways in Intestinal Epithelial Cell Lines Expressing Toll-Like Receptors1 , 2000, The Journal of Immunology.